1. Home
  2. RDHL vs IVP Comparison

RDHL vs IVP Comparison

Compare RDHL & IVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • IVP
  • Stock Information
  • Founded
  • RDHL 2009
  • IVP 2020
  • Country
  • RDHL Israel
  • IVP United States
  • Employees
  • RDHL N/A
  • IVP N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • IVP Diversified Commercial Services
  • Sector
  • RDHL Health Care
  • IVP Miscellaneous
  • Exchange
  • RDHL Nasdaq
  • IVP Nasdaq
  • Market Cap
  • RDHL 3.9M
  • IVP 3.3M
  • IPO Year
  • RDHL N/A
  • IVP 2023
  • Fundamental
  • Price
  • RDHL $1.23
  • IVP $0.71
  • Analyst Decision
  • RDHL
  • IVP
  • Analyst Count
  • RDHL 0
  • IVP 0
  • Target Price
  • RDHL N/A
  • IVP N/A
  • AVG Volume (30 Days)
  • RDHL 1.4M
  • IVP 508.6K
  • Earning Date
  • RDHL 08-28-2025
  • IVP 08-18-2025
  • Dividend Yield
  • RDHL N/A
  • IVP N/A
  • EPS Growth
  • RDHL N/A
  • IVP N/A
  • EPS
  • RDHL N/A
  • IVP N/A
  • Revenue
  • RDHL $8,042,999.00
  • IVP $15,399,751.00
  • Revenue This Year
  • RDHL $381.91
  • IVP N/A
  • Revenue Next Year
  • RDHL N/A
  • IVP N/A
  • P/E Ratio
  • RDHL N/A
  • IVP N/A
  • Revenue Growth
  • RDHL 23.17
  • IVP N/A
  • 52 Week Low
  • RDHL $1.17
  • IVP $0.63
  • 52 Week High
  • RDHL $15.34
  • IVP $189.25
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 33.65
  • IVP 31.57
  • Support Level
  • RDHL $1.17
  • IVP $0.71
  • Resistance Level
  • RDHL $3.31
  • IVP $0.83
  • Average True Range (ATR)
  • RDHL 0.31
  • IVP 0.06
  • MACD
  • RDHL -0.09
  • IVP 0.03
  • Stochastic Oscillator
  • RDHL 2.80
  • IVP 43.25

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About IVP Inspire Veterinary Partners Inc.

Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.

Share on Social Networks: